Use of PCR for TB bacteria on BAL in early diagnosis of tubercular lobitis;PCR per BK su BAL nella diagnostica precoce di lobite tubercolare

Infezioni in Medicina

Volumn 17, Issue 3, 2009, Pages 173-177

  Franco, Alfredo ^a   Aprea, Lucia ^a   Conte, Marco ^a   Manzillo, Elio ^a   Marocco, Alessandro ^a   Martucci, Fiorella ^a   Parrella, Roberto ^a   Pizzella, Teresa ^a   Simioli, Francesco ^a   Izzo, Crescenzo Maria ^a  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Lobitis; PCR; TBC

Indexed keywords

ETHAMBUTOL; ISONIAZID; PIPERACILLIN PLUS TAZOBACTAM; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BLOOD EXAMINATION; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG TREATMENT FAILURE; HUMAN; LUNG LAVAGE; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; SPUTUM CULTURE; THORAX RADIOGRAPHY; TUBERCULAR LOBITIS;

ANTITUBERCULAR AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; DNA, BACTERIAL; EARLY DIAGNOSIS; HUMANS; IMMUNOCOMPETENCE; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 70350627550     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. WHO Global Tuberculosis Control. Surveillance, Planning, Financing. Report 2008. Available on line at http://www.who.int/tb/publications/global- report/2008/pdf/fullreport.pdf.
2. Rappuoli R. From Pasteur to genomics: progress and challenges in infectious diseases. Nat Med. 10 (11), 1177-1185, 2004. (Pubitemid 39540432)
3. Che D., Antoine D. Immigrants and tuberculosis: recent epidemiological data. Med. Mal. Infect. 39 (3), 187-190, 2009.
4. Zager E.M., McNerney R. Multidrug-resistant tuberculosis. BMC Infect. Dis. 8 (10), 2008.
5. Lobue P., Sizemore C., Castro K.G. Plan to combat extensively drug-resistant tuberculosis recommendations of the federal tuberculosis task force. MMWR Recomm. Rep. 58 (RR3), 1-43, 2009.
6. Centers for Disease Control and Prevention (CDC). Controlling Tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep. 54. No. RR-12:19, 2005. Available on line at http://www.cdc.gov/MMWR/ PDF/rr/rr5412.pdf
7. Taegtmeyer M., Beeching N.J., Scott J., et al. The clinical impact of nucleic acid amplification tests on the diagnosis and management of tuberculosis in a British hospital. Thorax 63 (4), 317-321, 2008.
8. Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb. Mortal. Wkly. Rep. 16, 58 (1), 7-10, 2009. Available on line at http://www.ncbi.nlm. gov/pubmed/19145221.
9. Campos M., Quartin A., Mendes E., et al. Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test. Am. J. Respir. Crit. Care. Med. 178 (3), 300-305, 2008.
10. Pereira Gomes J.C., Pedreira W.L.J., Araujo E., et al. Impact of BAL in the management of pneumonia with treatment failure. Chest 118, 1739-1746, 2000.
11. Ziganshina L.E., Squire S.B. Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev. (1), CD004795, 2008.
12. Moadebi S., Harder C.K., Fitzgerald M.J., Elwood K.R., Marra F. Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs. 67 (14), 2077-2099, 2007.
13. Gottschalk A.W., Bachman J.W. Death following bilateral complete Achilles tendon rupture in a patient on fluoroquinolone therapy: a case report. J. Med. Case Reports 3 (1), 2009.
14. Sugimoto T., Kaneko H., Deji N., Koya D. Levofloxacin- induced Achilles tendon rupture in a patient with systemic microscopic polyangiitis. Mod. Rheumatol. 5 (3), 217-219, 2005. (Pubitemid 40983493)
15. de Jager P., van Altena R. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. Int. J. Tuberc. Lung Dis. 6 (7), 622-627, 2002. (Pubitemid 36898188)
16. Aouam K., Chaabane A., Loussaïef C., Ben Romdhane F., Boughattas N.A., Chakroun M. Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patient management. Med. Mal. Infect. 37 (5), 253-261, 2007. (Pubitemid 46754698)
17. Mitchison D.A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle 66 (3), 219-225, 1985. (Pubitemid 16150082)
18. Mitchison D.A. Mechanisms of the action of drugs in the short-course chemotherapy. Bull. Int. Union Tuberc. 60 (1-2), 36-40, 1985.
19. Richeldi L., Covi M., Ferrara G. et al. Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. Monaldi Arch. Chest Dis. 57 (1), 39-43, 2002. (Pubitemid 34873740)